ImmunityBio, Inc., NantKwest, Inc. - M&A Call Transcript
Good morning, everyone. My name is Pasha, and I will be your conference operator today. Thank you for standing by, and welcome to today's call with ImmunityBio and NantKwest. (Operator Instructions) A slide presentation accompanies today's webcast and participants are invited to follow along, advancing the slides themselves. The presentation may be accessed from the Investors section of the NantKwest website. It is also available on the ImmunityBio website. After the speaker's prepared remarks, there will be a short question-and-answer session.
Please note that this event is being recorded, and I will now turn the conference over to Sarah Singleton, Manager of Investor Relations and Communications at NantKwest. Sarah, please go ahead.
Thanks, Pasha, and thank you all for joining today's conference call to discuss the combination of ImmunityBio and NantKwest. On today's call are Dr. Patrick Soon-Shiong, Founder of ImmunityBio and NantKwest, who currently serves as CEO of ImmunityBio and Executive Chairman of NantKwest; and Rich Adcock,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |